» Articles » PMID: 31994864

Efficient Site-Specific Prokaryotic and Eukaryotic Incorporation of Halotyrosine Amino Acids into Proteins

Overview
Journal ACS Chem Biol
Specialties Biochemistry
Biology
Date 2020 Jan 30
PMID 31994864
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Post-translational modifications (PTMs) of protein tyrosine (Tyr) residues can serve as a molecular fingerprint of exposure to distinct oxidative pathways and are observed in abnormally high abundance in the majority of human inflammatory pathologies. Reactive oxidants generated during inflammation include hypohalous acids and nitric oxide-derived oxidants, which oxidatively modify protein Tyr residues via halogenation and nitration, respectively, forming 3-chloroTyr, 3-bromoTyr, and 3-nitroTyr. Traditional methods for generating oxidized or halogenated proteins involve nonspecific chemical reactions that result in complex protein mixtures, making it difficult to ascribe observed functional changes to a site-specific PTM or to generate antibodies sensitive to site-specific oxidative PTMs. To overcome these challenges, we generated a system to efficiently and site-specifically incorporate chloroTyr, bromoTyr, and iodoTyr, and to a lesser extent nitroTyr, into proteins in both bacterial and eukaryotic expression systems, relying on a novel amber stop codon-suppressing mutant synthetase (haloTyrRS)/tRNA pair derived from the pyrrolysine synthetase system. We used this system to study the effects of oxidation on HDL-associated protein paraoxonase 1 (PON1), an enzyme with important antiatherosclerosis and antioxidant functions. PON1 forms a ternary complex with HDL and myeloperoxidase (MPO) . MPO oxidizes PON1 at tyrosine 71 (Tyr71), resulting in a loss of PON1 enzymatic function, but the extent to which chlorination or nitration of Tyr71 contributes to this loss of activity is unclear. To better understand this biological process and to demonstrate the utility of our GCE system, we generated PON1 site-specifically modified at Tyr71 with chloroTyr and nitroTyr in and mammalian cells. We demonstrate that either chlorination or nitration of Tyr71 significantly reduces PON1 enzymatic activity. This tool for site-specific incorporation of halotyrosine will be critical to understanding how exposure of proteins to hypohalous acids at sites of inflammation alters protein function and cellular physiology. In addition, it will serve as a powerful tool for generating antibodies that can recognize site-specific oxidative PTMs.

Citing Articles

Engineering Pyrrolysine Systems for Genetic Code Expansion and Reprogramming.

Dunkelmann D, Chin J Chem Rev. 2024; 124(19):11008-11062.

PMID: 39235427 PMC: 11467909. DOI: 10.1021/acs.chemrev.4c00243.


Cracking the Code: Reprogramming the Genetic Script in Prokaryotes and Eukaryotes to Harness the Power of Noncanonical Amino Acids.

Jann C, Giofre S, Bhattacharjee R, Lemke E Chem Rev. 2024; 124(18):10281-10362.

PMID: 39120726 PMC: 11441406. DOI: 10.1021/acs.chemrev.3c00878.


Metabolomic screening of radioiodine refractory thyroid cancer patients and the underlying chemical mechanism of iodine resistance.

Zheng W, Tang X, Dong J, Feng J, Chen M, Zhu X Sci Rep. 2024; 14(1):10546.

PMID: 38719979 PMC: 11079026. DOI: 10.1038/s41598-024-61067-6.


Generating Efficient Pyrrolysyl-tRNA Synthetases for Structurally Diverse Non-Canonical Amino Acids.

Avila-Crump S, Hemshorn M, Jones C, Mbengi L, Meyer K, Griffis J ACS Chem Biol. 2022; 17(12):3458-3469.

PMID: 36383641 PMC: 9833845. DOI: 10.1021/acschembio.2c00639.


Engineered bacterial host for genetic encoding of physiologically stable protein nitration.

Koch N, Baumann T, Nickling J, Dziegielewski A, Budisa N Front Mol Biosci. 2022; 9:992748.

PMID: 36353730 PMC: 9638147. DOI: 10.3389/fmolb.2022.992748.


References
1.
Liu X, Jiang L, Li J, Wang L, Yu Y, Zhou Q . Significant expansion of fluorescent protein sensing ability through the genetic incorporation of superior photo-induced electron-transfer quenchers. J Am Chem Soc. 2014; 136(38):13094-7. DOI: 10.1021/ja505219r. View

2.
DiDonato J, Huang Y, Aulak K, Even-Or O, Gerstenecker G, Gogonea V . Function and distribution of apolipoprotein A1 in the artery wall are markedly distinct from those in plasma. Circulation. 2013; 128(15):1644-55. PMC: 3882895. DOI: 10.1161/CIRCULATIONAHA.113.002624. View

3.
Bhattacharyya T, Nicholls S, Topol E, Zhang R, Yang X, Schmitt D . Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk. JAMA. 2008; 299(11):1265-76. PMC: 3014051. DOI: 10.1001/jama.299.11.1265. View

4.
Tang W, Wu Y, Mann S, Pepoy M, Shrestha K, Borowski A . Diminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failure. Circ Heart Fail. 2010; 4(1):59-64. PMC: 3023838. DOI: 10.1161/CIRCHEARTFAILURE.110.958348. View

5.
Harel M, Aharoni A, Gaidukov L, Brumshtein B, Khersonsky O, Meged R . Structure and evolution of the serum paraoxonase family of detoxifying and anti-atherosclerotic enzymes. Nat Struct Mol Biol. 2004; 11(5):412-9. DOI: 10.1038/nsmb767. View